Expanding India’s vaccine basket, the Central Drug Authority has approved the Serum Institute of India’s Covid-19 vaccine Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation.

The announcement by Union Health Minister Mansukh Mandaviya on Tuesday came a day after the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorisation to Covovax and Corbevax with certain conditions. It also had recommended granting restricted emergency use approval to the drug Molnupiravir for treatment of adult patients with Covid-19 and who have high risk of progression of the disease.